253787-45-0 Usage
Uses
Used in Organic Synthesis:
Methyl-8-bromoquinoline-5-carboxylate is used as a building block in organic synthesis for the creation of heterocyclic compounds. Its unique structure allows for the formation of various complex organic molecules, making it a valuable component in the synthesis of pharmaceuticals and other organic compounds.
Used in Pharmaceutical Research:
In pharmaceutical research, methyl-8-bromoquinoline-5-carboxylate is used as a precursor for the development of new pharmacological agents. Its quinoline core and functional groups enable the design and synthesis of novel drug candidates with potential therapeutic applications.
Used in Antitumor Applications:
Methyl-8-bromoquinoline-5-carboxylate has been investigated for its potential antitumor properties. Its ability to interact with cellular targets and inhibit tumor growth makes it a promising candidate for the development of anticancer drugs.
Used in Antimicrobial Applications:
methyl-8-bromoquinoline-5-carboxylate has also shown potential as an antimicrobial agent. Its ability to disrupt microbial processes and inhibit the growth of various pathogens makes it a candidate for the development of new antimicrobial drugs and treatments.
Used in Chemical Research:
Methyl-8-bromoquinoline-5-carboxylate is utilized in chemical research to study the properties and reactivity of quinoline derivatives. Its unique structure provides insights into the behavior of similar compounds and contributes to the understanding of organic and medicinal chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 253787-45-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,5,3,7,8 and 7 respectively; the second part has 2 digits, 4 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 253787-45:
(8*2)+(7*5)+(6*3)+(5*7)+(4*8)+(3*7)+(2*4)+(1*5)=170
170 % 10 = 0
So 253787-45-0 is a valid CAS Registry Number.
253787-45-0Relevant academic research and scientific papers
BRIDGED BICYCLIC COMPOUNDS AS FARNESOID X RECEPTOR MODULATORS
-
Paragraph 1356-1357, (2019/05/15)
The present invention provides compounds of Formula (I): or stereoisomers, tautomers, or pharmaceutically acceptable salts or solvates thereof, wherein all the variables are as defined herein. These compounds modulate the activity of farnesoid X receptor
